Document is current
Any future updates will be listed below
-
Authors
Smaling, Hanneke J.A.
Jingyuan, Xu
Nakanishi, Miharu
Shinan-Altman, Shiri
Mehr, David R.
Radbruch, Lukas
Gaertner, Jan
Werner, Perla
Achterberg, Wilco P.
van der Steen, Jenny T. https://orcid.org/0000-0002-9063-7501
-
Funding
Funding for this research was provided by:
European Research Council (771483, 771483, 771483)
- License Information
-
More Information
Article History
Received: 18 August 2023
Accepted: 22 August 2023
First Online: 27 September 2023
Declarations
:
: For the Netherlands, the CONT-END acceptability study has been approved by the Medical Ethics Committee - Leiden The Hague Delft (NL72354.058.19). For the US, the Institutional Review Board University of Missouri – Columbia reviewed and approved the study (2046522). For Japan, the study protocol has been approved by the Ethics Committee Tohoku University Graduate School of Medicine (2021-1-1105; approved revision 2022-1-1081). The Ethics Committee of the School of Social Work at Bar Ilan University has approved of the study protocol for Israel (012213). The Ethics Committee of Nord-West and Central Swiss approved the study (2022 − 00630). In Germany, the Ethics Committee of the Rheinische Friedrich-Wilhelms-Universität Bonn approved the study (304/22).
: The protocol of the pilot study has been reviewed by the Medical Ethics Committee - Leiden The Hague Delft (METC LLD), and they declared it to be exempt from the Medical Research Involving Human Subjects Act (WMO), protocol number: N19.098. Informed consent will be obtained from all participants.
: Not applicable.
: The authors declare no competing interests.
